Delivery Order SPE2DB25D3201-SPE2DB26FNNRG
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Capecitabine 500 mg tablets (120-count units) valued at $1,628.98. This competitive delivery order, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,775.01 delivery order to AmerisourceBergen Drug Corp for Capecitabine 500 mg tablets (120-count) on April 23, 2025, with completion scheduled for April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing under a delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Capecitabine 500 mg tablets in a quantity of 120 units, with a ceiling value of $1,093.68. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract was not set aside for any particular business category and was competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,982,789 units of the medication Capecitabine 500 mg tablets. The contract has a ceiling value of $1,938.09 and a period of performance through March 18, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,852.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 4,565,070,201 Capecitabine 500 mg tablets, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the...
- The Defense Logistics Agency Troop Support Medical awarded a $392,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 boxes of 500mg Capecitabine tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 16, 2023 through August 17, 2023. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill requirements for oncology medications...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Capecitabine 150 mg tablets. The contract, valued at $1,094.60, has a period of performance through May 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a...
- The Defense Logistics Agency awarded a $3,408.27 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 120 tablets of 500 mg Capecitabine. Performance will occur in Conshohocken, Pennsylvania by October 23, 2023. The delivery order was awarded on October 20, 2023 under an existing vehicle and does not have a set-aside designation. As the DLA supports military treatment facilities, this order for the cancer treatment medication will help ensure availability for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Capecitabine 500 mg tablets. The contract has a ceiling value of $6,330.32 and an ultimate completion date of October 19, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- Defense Logistics Agency awarded a $308 firm fixed price delivery order contract to Amerisourcebergen Drug Corp for the purchase of 120 capsules of 500mg Capecitabine tablets. The contract has no set-aside designation and requires delivery to a location in Conshohocken, Pennsylvania by October 13, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor under this contract to supply pharmaceutical products for DLA's medical...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNRGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Capecitabine 500 mg tablets (120 count) with a ceiling value of $1,147.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Capecitabine, a chemotherapy medication, represents one of the specialized pharmaceutical products within the company's extensive therapeutic portfolio delivered through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/27/25 |